NASDAQ:INO   Inovio Pharmaceuticals, Inc.
As a disclosure I am quite new to reading charts, but i have been learning. In this chart you can see that the consolidation of the highs and lows are funneling towards $13 a share. But keep in mind that a failing testing procedure can break the lows into a new support line. As the earnings are coming up, we may find a price rally.
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。